GoHealth Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GoHealth, Inc. (NASDAQ: GOCO), a health insurance marketplace, announced management appointments effective March 17, 2023. The company granted equity-based awards under its 2021 Inducement Award Plan to new executives: Chief Marketing Officer Steve Moffat received 75,000 restricted stock units (RSUs), Chief People Officer Alison Moriarty received 50,000 RSUs, and Vice President of Investor Relations John Shave received 25,000 RSUs. These RSUs will vest over three years, contingent on continued service with the company. The moves aim to drive growth and enhance leadership within GoHealth's Medicare-focused operations.
- Appointment of experienced executives to key positions to strengthen leadership.
- Equity-based incentives align executive interests with shareholder value.
- Inducement grants may enhance employee retention and performance.
- No immediate financial metrics provided to assess impact.
- -
The inducement grants consisted of 75,000 restricted stock units for shares of the Company's common stock ("RSUs") issued to
Contacts
For Investors
IR@gohealth.com
For Media
Pressinquiries@gohealth.com
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/gohealth-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-301775212.html
SOURCE
FAQ
What equity awards were granted by GoHealth on March 17, 2023?
How will the restricted stock units (RSUs) vest for GoHealth executives?
What is the purpose of GoHealth's equity grants under the 2021 Inducement Award Plan?